Eyelit Technologies to drive operational excellence and advanced automation at SCD, empowering SCD with integrated planning, tool automation, and MES capabilities for complex wafer processes. SCD’s ...

One of the most frightening things about hypertrophic cardiomyopathy (HCM) is that it raises one’s risk for sudden cardiac death (SCD). If you or a loved one are affected by this rare genetic heart ...

Throughout medical school and into residency, Edward “Donnell” Ivy, MD, MPH, wanted to become a pediatrician, so he could help children avoid the suffering he’d experienced as a child with sickle cell ...

81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...

SCD seeks total returns with a primary focus on income, investing globally in companies with strong fundamentals and clear market advantages. The fund uses leverage to enhance returns, with interest ...

This article is part of a Health Affairs Forefront series on “The Future of Sickle Cell Disease Research and Care” with support from the American Society of Hematology. The articles in the series are ...

Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...

This article is part of a Health Affairs Forefront series on “The Future of Sickle Cell Disease Research and Care” with support from the American Society of Hematology. The articles in the series are ...

FDA approves SeaStar Medical's SCD-ADULT study for treating acute heart failure with renal issues, funded by a $3.6 million NIH grant. SeaStar Medical Holding Corporation announced that the U.S. FDA ...